TEVA PHARMACEUTICAL INDUSTRIES LIMITED Inactive Instrument
Calendar Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Chart calendar Teva Pharmaceutical Industries Limited
f6754b6516111af1bb06313c.11pKy77L56GZt2HlCQPBZe26BxEvlCE6oTXcuqwXDtg.si4To_2DkZbR9A2DZy6zN7njQCRpp0RsyVml29VeaoGmN36t3b6t1c2DUQ~386443da6f497ccdaf7197d5898d8dc2
Upcoming events on Teva Pharmaceutical Industries Limited
Past events on Teva Pharmaceutical Industries Limited
| 08/05/2024 05:30 pm | Q1 2024 Earnings Call |
| 08/05/2024 04:30 pm | Q1 2024 Earnings Release |
| 03/04/2024 | Schizophrenia International Research Society Congress |
| 31/01/2024 06:30 pm | Q4 2023 Earnings Call |
| 31/01/2024 05:30 pm | Q4 2023 Earnings Release |
| 08/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 28/11/2023 06:50 pm | Evercore ISI HealthCONx Conference |
| 08/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 08/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 02/11/2023 | Huntington Study Group Meeting |
| 04/10/2023 05:30 pm | Sanofi Pharmaceutical Industry Company and Teva Pharmaceutical Industries Ltd Collaboration Agreemen |
| 11/09/2023 06:10 pm | Morgan Stanley Global Healthcare Conference |
| 10/09/2023 12:30 am | Psych Congress |
| 08/09/2023 | Psych Congress - Poster #104 |
| 08/09/2023 | Psych Congress - Poster #130 |
| 08/09/2023 | Psych Congress - Poster #90 |
| 08/09/2023 | Psych Congress - Poster #134 |
| 08/09/2023 | Psych Congress - Poster #109 |
| 08/09/2023 | Psych Congress - Poster #139 |
| 08/09/2023 | Psych Congress - Poster #110 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16 887 17 254 -2.13% | 16 659 16 599 0.36% | 15 878 16 125 -1.53% | 14 925 14 952 -0.18% | 15 846 15 349 3.24% | 15 920 |
|
EBITDA Million USD | Released Forecast Spread | 4 685 4 678 0.16% | 4 912 4 899 0.26% | 4 911 4 862 1.01% | 4 598 4 702 -2.22% | 4 818 4 520 6.58% | 4 751 |
|
EBIT Million USD | Released Forecast Spread | 4 142 4 108 0.82% | 4 388 4 333 1.27% | 4 401 4 355 1.05% | 4 139 4 163 -0.57% | 4 361 4 050 7.67% | 4 259 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1 265 1 262 -200.22% | -4 406 1 060 -515.66% | 658 1 625 -59.51% | 0,00 0,00 - | -624 -916 31.88% | -99,0 |
|
Net income Million USD | Released Forecast Spread | -999 -806 -23.87% | -3 990 -3 864 -3.27% | 417 954 -56.3% | -2 353 -494 -375.86% | -559 343 -262.9% | 820 |
|
EPS USD | Released Forecast Spread | -0,91 -0,73 -23.86% | -3,64 -3,48 -4.56% | 0,38 0,76 -50.04% | -2,12 -0,45 -370.01% | -0,50 -0,24 -107.75% | 0,94 |
| Announcement Date | 12/02/20 | 10/02/21 | 09/02/22 | 08/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 661 3 754 -2.48% | 3 786 3 775 0.29% | 3 595 3 854 -6.72% | 3 884 3 905 -0.54% | 3 661 3 589 2% | 3 878 3 720 4.24% | 3 850 3 736 3.05% | 4 457 4 010 11.15% | 3 819 3 740 2.12% | 4 020 | 4 030 | 4 104 | 3 743 | 3 982 |
|
EBITDA Million USD | Released Forecast Spread | 1 135 1 096 3.54% | 1 134 1 138 -0.39% | 1 089 1 181 -7.77% | 1 240 1 332 -6.93% | 899 1 119 -19.69% | 1 125 1 079 4.22% | 1 134 1 186 -4.41% | 1 660 1 394 19.06% | 1 005 1 049 -4.18% | 1 177 | 1 220 | 1 301 | ||
|
EBIT Million USD | Released Forecast Spread | 1 013 976 3.84% | 1 019 1 012 0.67% | 977 1 048 -6.8% | 1 130 1 165 -3.02% | 785 984 -20.19% | 1 011 956 5.8% | 1 020 1 063 -4.04% | 1 546 1 251 23.56% | 892 920 -3.09% | 1 053 | 1 096 | 1 156 | 1 027 | 1 121 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -971 403 -340.94% | -1 160 393 -395.17% | -1 100 430 -355.81% | 75,0 443 -83.07% | 507 180 181.67% | -467 141 -431.21% | 107 | 127 | 133 | |||||
|
Net income Million USD | Released Forecast Spread | -955 335 -384.9% | -232 236 -198.45% | 56,0 96,7 -42.1% | -1 221 584 -309.12% | -205 58,2 -452.48% | -863 -12,2 -6951.9% | 80,0 -192 141.73% | 461 1 055 -56.3% | -139 32,0 -534.38% | 39,0 | 56,5 | -15,8 | ||
|
EPS USD | Released Forecast Spread | -0,86 0,28 -404.92% | -0,21 0,06 -475.6% | 0,05 0,09 -42.12% | -1,10 0,50 -319.89% | -0,18 0,05 -447.89% | -0,77 -0,01 -7023.03% | 0,07 -0,35 119.73% | 0,41 0,53 -21.99% | -0,12 -0,05 -148.76% | -0,36 | 0,00 | 0,86 | ||
| Announcement Date | 03/05/22 | 26/07/22 | 03/11/22 | 08/02/23 | 10/05/23 | 02/08/23 | 08/11/23 | 31/01/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Teva Pharmaceutical Industries Limited
| 10/05/2024 08:31 pm | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 04:20 pm | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 04:16 pm | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
| 10/05/2024 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 10/05/2024 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
| 10/05/2024 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:32 am | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
| 09/05/2024 07:28 pm | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
| 09/05/2024 06:36 pm | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
